Here are five points:
1. Wells Fargo had previously rated the company “market perform.”
2. Mazor Robotics generated revenues of $6.4 million for the first quarter of 2016, a 42 percent increase from $4.5 million for the same period last year.
3. The company also reported United States-generated revenue more than doubled to $5.6 million in this quarter, from $2.7 million in 2015’s first quarter.
4. The company has a market cap of $226 million.
5. The new deal with Medtronic includes the co-promotion and development and distribution of Mazor products. Medtronic also made an equity investment in Mazor.
More articles on devices:
Histogenics acquires sole development, marketing rights for NeoCart in Japan: 5 key notes
Study: Cartiva SCI an effective for toe osteoarthritis treatment — 4 points
Medtronic invests in Mazor, inks commercial agreement: 6 things to know
